These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Can left ventricular pathological hypertrophy in arterial hypertension be distinguished from physiological hypertrophy due to sports?]. Franz IW. Dtsch Med Wochenschr; 2002 Feb 01; 127(5):225-6; author reply 226-7. PubMed ID: 11822001 [No Abstract] [Full Text] [Related]
4. [Importance of detection of hypertensive reaction to physical loading in patients with or without left ventricular hypertrophy and arterial hypertension]. Ivanov AP, Saĭeda EA, El'gardt IA, Sdobniakova NS. Klin Med (Mosk); 2009 Feb 01; 87(7):24-6. PubMed ID: 19705786 [Abstract] [Full Text] [Related]
5. Hypertension and heart failure: a dysfunction of systole, diastole or both? Yip GW, Fung JW, Tan YT, Sanderson JE. J Hum Hypertens; 2009 May 01; 23(5):295-306. PubMed ID: 19037230 [Abstract] [Full Text] [Related]
9. [Recomendations on management of left ventricular hypertrophy in athletes. The Working Group of Sports Cardiology of the French Society of Cardiology]. Brion R, Groupe de Travail Cardiologie du Sport de la Société Française de Cardiologie. Arch Mal Coeur Vaiss; 2007 Mar 01; 100(3):195-206. PubMed ID: 17536423 [No Abstract] [Full Text] [Related]
10. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients. Demir M, Acartürk E, Inal T, Attila G, Dönmez Y, Avkaroğullari M, Cayli M. Cardiovasc Pathol; 2007 Mar 01; 16(2):69-74. PubMed ID: 17317538 [Abstract] [Full Text] [Related]
11. Clinical advances in diastolic heart failure. McManus D, Aurigemma G. Minerva Cardioangiol; 2006 Dec 01; 54(6):695-713. PubMed ID: 17167382 [Abstract] [Full Text] [Related]
12. [The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension]. Rubattu S, Volpe M, Raman V, Lindpaintner K. Cardiologia; 1997 Jan 01; 42(1):47-50. PubMed ID: 9118154 [No Abstract] [Full Text] [Related]
13. Suggested new upper limit of physiologic cardiac hypertrophy determined in Japanese ultramarathon runners must be interpreted cautiously. Scharhag J, Urhausen A, Kindermann W. J Am Coll Cardiol; 2004 Jul 21; 44(2):470-1; author reply 471. PubMed ID: 15261953 [No Abstract] [Full Text] [Related]
15. Refining patterns of left ventricular hypertrophy using cardiac MRI: "brother, can you spare a paradigm?". Chinali M, Aurigemma GP. Circ Cardiovasc Imaging; 2010 Mar 21; 3(2):129-31. PubMed ID: 20233860 [No Abstract] [Full Text] [Related]
16. The role of echocardiography in the evaluation of cardiac re-modelling and differentiation between physiological and pathological hypertrophy in teenagers engaged in competitive amateur sports. Sulovic LS, Mahmutovic M, Lazic S, Sulovic N. Cardiol Young; 2017 May 21; 27(4):706-712. PubMed ID: 27751193 [Abstract] [Full Text] [Related]
19. Left ventricular mass, diastolic dysfunction, and hypertension. Gottdiener JS. Adv Intern Med; 1993 May 21; 38():31-56. PubMed ID: 8438643 [No Abstract] [Full Text] [Related]
20. Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population. Shipilova T, Pshenichnikov I, Kaik J, Volozh O, Abina J, Kalev M, Lass J, Karai D. Blood Press; 2003 May 21; 12(1):12-8. PubMed ID: 12699130 [Abstract] [Full Text] [Related] Page: [Next] [New Search]